NuCana Plc (NCNA)
4.18
-0.10
(-2.34%)
USD |
NASDAQ |
Dec 10, 14:24
NuCana EPS Diluted (Quarterly): -0.1348 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -0.2955 |
| Mereo BioPharma Group Plc | -0.0436 |
| Bicycle Therapeutics Plc | -0.8476 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3789M |
| Total Expenses (Quarterly) | 0.3789M |
| Enterprise Value | -16.00M |
| Earnings Yield | -3.91K% |
| Normalized Earnings Yield | -3610.00 |